FIELD: medicine, pharmaceutics.
SUBSTANCE: aqueous suspensions contain riluzol or a pharmaceutical acceptable salt, at least one surfactant, and at least one suspending agent. Riluzol is found in the amount of approximately 0.1% to approximately 20% (weight/volume) and characterized by a particle size less than approximately 200 mcm. The surfactant is specified in anionic surfactants, nonionic surfactant or a mixture thereof. The suspending agent is specified in smectic clays, microcrystalline cellulose, natural gums or a mixture thereof.
EFFECT: suspension of riluzol according to the invention are physically and chemically stable, has the common local (oral) anaesthetic effect specific for riluzol.
19 cl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION CONTAINING 5-METHYL-2-(2′-CHLORO-6′- FLUOROANILINE)PHENYLACETIC ACID | 2004 |
|
RU2363462C2 |
COMPOSITION FOR FACE WASHING AS EMULSION CONTAINING BENZOYL PEROXIDE | 2013 |
|
RU2647479C2 |
METHOD OF PREPARING STABLE ARYLPYRROL PARTICLES, STABLE ARYLPYRROL PARTICLES, AND SUSPENSION CONCENTRATE COMPOSITION | 1997 |
|
RU2197087C2 |
PHYSICALLY AND CHEMICALLY STABLE ORAL SUSPENSION OF GIVINOSTAT | 2016 |
|
RU2721396C2 |
GEL DETERGENT COMPOSITION CONTAINING BENZOYL PEROXIDE (BPO) | 2013 |
|
RU2706695C2 |
ORAL CARE COMPOSITIONS | 2021 |
|
RU2757224C1 |
ACNE TREATING METHOD AND COMPOSITION AGAINST ACNE | 2013 |
|
RU2613107C2 |
PAZOPANIB COMPOSITION | 2012 |
|
RU2616500C2 |
CONTROLLED RELEASE ANALGETIC SUSPENSIONS | 2004 |
|
RU2386434C2 |
PROLONGED STORAGE DICYCLANIL-BASED AQUEOUS SUSPENSION AND NON-AQUEOUS SUSPENSION COMPOSITIONS FOR APPLICATION BY WASHING AND SPRAYING, SUITABLE FOR PREVENTING AND TREATING INSECT INFESTATION IN ANIMALS | 2010 |
|
RU2554795C2 |
Authors
Dates
2013-11-20—Published
2010-03-02—Filed